Publication | Closed Access
A<sup>195</sup>Hg<sup>m</sup>-<sup>195</sup>Au<sup>m</sup>generator for use in first-pass nuclear angiocardiography
12
Citations
14
References
1983
Year
Heart FailureRadiation ExposureFirst-pass Nuclear AngiocardiographyAnger DesignRadiation TestingRadiopharmaceutical TherapyRadiation OncologyCardiologyNuclear MedicineCardiac MechanicRadiologyHealth SciencesRadiation TherapyRadionuclide TherapyIonizing RadiationRadiation DamageDosimetryRadiation DoseRadiopharmaceuticalsElectrophysiologyMedicine
The development of a mercury-195m/gold-195m radionuclide generator system is described, together with the results of preliminary experiments in animals and in man. The daughter radionuclide has a half-life of 30.5 s with a principal gamma emission at 262 keV, ideal for use with the multicrystal camera but suitable also in conjunction with the Anger design. The half-life of the parent radionuclide is 40 h. The eluant in current use is 2.5 mM sodium cyanide, the column being stored under 2% sodium nitrate solution when not in use to prevent radiation damage. Generators capable of delivering 550 MBq of 195Aum in a 0.4 ml bolus have been used for first-pass nuclear angiocardiography, the half-life being long enough to permit administration via peripheral intravenous injection. The radiation dose associated with this radionuclide is much lower than that from conventional 99Tcm-labelled radiopharmaceuticals, permitting multiple sequential studies, even on children.
| Year | Citations | |
|---|---|---|
Page 1
Page 1